Friday, October 18, 2024
spot_img

LifeStance to Host Third Quarter 2024 Earnings Conference Call on November 7, 2024

SCOTTSDALE, Ariz., Oct. 17, 2024 (GLOBE NEWSWIRE) — LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its third quarter 2024 earnings release before the market opens on Thursday, November 7, 2024.

LifeStance will host a live earnings conference call to discuss third quarter results on November 7, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 2787723, or ask to be joined into the LifeStance call.

A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance Investor Relations website (https://investor.lifestance.com), where related materials will be posted prior to the conference call.

A replay of the webcast will be available after the conclusion of the conference call and can be accessed on the LifeStance Investor Relations website.

About LifeStance Health
Founded in 2017, LifeStance (NASDAQ: LFST) is reimagining mental health. We are one of the nation’s largest providers of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions. Our mission is to help people lead healthier, more fulfilling lives by improving access to trusted, affordable and personalized mental health care. LifeStance and its supported practices employ nearly 7,000 psychiatrists, advanced practice nurses, psychologists and therapists and operate across 33 states and more than 550 centers. To learn more, please visit www.LifeStance.com.

CONTACT: Investor Contact:
Monica Prokocki
Vice President of Finance and Investor Relations
[email protected]

Media Contact:
Brooke Matthews
Senior Director of Communications
[email protected]

Powered by SlickText.com

Hot this week

Form 8.5 (EPT/RI) – Brown (N.) Group plc

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY...

Nxera Pharma to Host R&D Day 2024

Nxera Pharma Co., Ltd. will hold an R&D Day...

Net Asset Value(s)

                 WisdomTree Issuer plc – Daily Fund Prices 17-October-24        WisdomTree...

Holding(s) in Company

TR-1: Standard form for notification of major holdings ...

Topics

Form 8.5 (EPT/RI) – Brown (N.) Group plc

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY...

Nxera Pharma to Host R&D Day 2024

Nxera Pharma Co., Ltd. will hold an R&D Day...

Net Asset Value(s)

                 WisdomTree Issuer plc – Daily Fund Prices 17-October-24        WisdomTree...

Holding(s) in Company

TR-1: Standard form for notification of major holdings ...

Huhtamaki Expands Its Capacity for Fiber Lid Production to Lurgan, Northern Ireland

HUHTAMÄKI OYJ PRESS RELEASE 18.10.2024 AT 12:00 EEST  ...

Ohmyhome to Announce Q3 2024 Growth Updates

Further Growth Updates from Previously Reported 106% Y-o-Y Growth...
spot_img

Related Articles

Popular Categories

spot_img